SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007416
Filing Date
2021-05-17
Accepted
2021-05-17 16:35:26
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20210331x10q.htm 10-Q 841549
2 EX-31.1 rsls-20210331ex311fda2ec.htm EX-31.1 11673
3 EX-31.2 rsls-20210331ex3120dfec7.htm EX-31.2 11980
4 EX-32.1 rsls-20210331ex321111572.htm EX-32.1 9404
5 EX-32.2 rsls-20210331ex3228a5a5f.htm EX-32.2 9278
  Complete submission text file 0001558370-21-007416.txt   3587703

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20210331.xml EX-101.INS 591789
7 EX-101.SCH rsls-20210331.xsd EX-101.SCH 32504
8 EX-101.CAL rsls-20210331_cal.xml EX-101.CAL 48456
9 EX-101.DEF rsls-20210331_def.xml EX-101.DEF 111306
10 EX-101.LAB rsls-20210331_lab.xml EX-101.LAB 283510
11 EX-101.PRE rsls-20210331_pre.xml EX-101.PRE 232014
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 21931449
SIC: 3845 Electromedical & Electrotherapeutic Apparatus